Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers

Wound Repair and Regeneration

Volumn 17, Issue 6, 2009, Pages 832-839

  Moor, Andrea N ^a   Vachon, David J ^b   Gould, Lisa J ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Aegis Biosciences LLC   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORISONDAMINE; COLLAGENASE 3; CYTOKINE; FIBRONECTIN; GELATINASE A; GELATINASE B; GROWTH FACTOR; INTERSTITIAL COLLAGENASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE;

ADULT; AGED; ARTICLE; CASE REPORT; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROCOCCUS; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG ULCER; MICROBIAL COLONIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PSEUDOMONAS AERUGINOSA; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; WOUND CARE; WOUND FLUID; WOUND HEALING; ZYMOGRAPHY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BANDAGES, HYDROCOLLOID; BIOPSY; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; LEG ULCER; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PEPTIDE HYDROLASES; SULFUR COMPOUNDS;

EID: 70350644808     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2009.00547.x     Document Type: Article

References (26)

1. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, Marston WA. Multiplexed analysis of matrix metalloproteinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapy. Wound Repair Regen 2008 16 : 642 648.
2. Grinnell F, Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 1996 106 : 335 341.
3. Herouy Y, Trefzer D, Zimpfer U, Schopf E, Wanscheidt W, Norgauer J. Matrix metalloproteinases and venous leg ulceration. Eur J Dermatol 2000 10 : 173 180.
4. Palolahti M, Lauharanta J, Stephens RW, Kuusela P, Vaheri A. Proteolytic activity in leg ulcer exudate. Exp Dermatol 1993 2 : 29 37.
5. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993 101 : 64 8.
6. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996 107 : 743 748.
7. Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2001 CD000265.
8. Falanga V. Care of venous leg ulcers. Ostomy Wound Manage 1999 45 (1A, Suppl.) : 33S 43S quiz 4S-5S.
9. Hansson C, Andersson E, Swanbeck G. A follow-up study of leg and foot ulcer patients. Acta Derm Venereol 1987 67 : 496 500.
10. Allman RM. Outcomes in prospective studies and clinical trials. Adv Wound Care 1995 8 (Suppl.) : 61 4.
11. O'Brien JF, Grace PA, Perry IJ, Hannigan A, Clarke Moloney M, Burke PE. Randomized clinical trial and economic analysis of four-layer compression bandaging for venous ulcers. Br J Surg 2003 90 : 794 798.
12. Troyer-Caudle J, Harris AH. Home care for venous leg ulcers. Home Care Provid 1996 1 : 119 128 quiz 28-30.
13. Gendron R, Grenier D, Sorsa T, Mayrand D. Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine. Clin Diagn Lab Immunol 1999 6 : 437 439.
14. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 2002 10 : 26 37.
15. Liu Y, Min D, Bolton T, Nubé V, Twigg SM, Yue DK, McLennan SV. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 2009 32 : 117 119.
16. Grinnell F, Ho CH, Wysocki A. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 1992 98 : 410 416.
17. Ongenae KC, Phillips TJ, Park HY. Level of fibronectin mRNA is markedly increased in human chronic wounds. Dermatol Surg 2000 26 : 447 451.
18. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002 115 (Part 20) : 3861 3863.
19. Marom B, Rahat MA, Lahat N, Weiss-Cerem L, Kinarty A, Bitterman H. Native and fragmented fibronectin oppositely modulate monocyte secretion of MMP-9. J Leukoc Biol 2007 81 : 1466 1476.
20. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF III. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001 276 : 10229 10233.
21. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001 69 : 851 859.
22. Boussac M, Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000 21 : 665 672.
23. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999 97 : 889 901.
24. Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, Fitzgerald O, Roth J. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003 42 : 1383 1389.
25. Robert L, Hornebeck W. Elastin and elastases. Boca Raton, FL : CRC Press, 1989.
26. Bieth J. Elastases: catalytic and biological properties. In : Mecham R, editor. Regulation of matrix accumulation. New York : Academic Press, 1986 : 217 320.